PURPLE BIOTECH LTD. Cash And Cash Equivalents
PURPLE BIOTECH LTD. (PPBT) had Cash And Cash Equivalents of $8.72 million as of 2025-12-31, per its 20-F filed 2026-03-19.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-19
- 2025-12-31: Cash And Cash Equivalents $8.72M.
- 2024-12-31: Cash And Cash Equivalents $7.40M.
- 2023-12-31: Cash And Cash Equivalents $14.49M.
- 2022-12-31: Cash And Cash Equivalents $15.03M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $8.72M 20-F · filed 2026-03-19 |
| 2024-12-31 | $7.40M 20-F · filed 2026-03-19 |
| 2023-12-31 | $14.49M 20-F · filed 2026-03-19 |
| 2022-12-31 | $15.03M 20-F · filed 2026-03-19 |
| 2021-12-31 | $10.89M 20-F · filed 2025-03-10 |
| 2020-12-31 | $11.25M 20-F · filed 2024-03-05 |
| 2019-12-31 | $4.38M 20-F · filed 2023-03-03 |
| 2019-06-30 | $2.76M 6-K · filed 2019-08-26 |
| 2018-12-31 | $5.16M 20-F · filed 2022-03-09 |
| 2018-06-30 | $5.36M 6-K · filed 2019-08-26 |
| 2017-12-31 | $3.95M 20-F · filed 2021-03-16 |
| 2017-06-30 | $527.00K 6-K · filed 2018-09-17 |
| 2016-12-31 | $6.76M 20-F · filed 2020-03-23 |
| 2015-12-31 | $10.56M 20-F · filed 2019-03-26 |
| 2014-12-31 | $1.31M 20-F · filed 2018-03-05 |